scispace - formally typeset
C

Carlo Cervellati

Researcher at University of Ferrara

Publications -  133
Citations -  3155

Carlo Cervellati is an academic researcher from University of Ferrara. The author has contributed to research in topics: Medicine & Oxidative stress. The author has an hindex of 24, co-authored 112 publications receiving 2369 citations.

Papers
More filters
Journal ArticleDOI

Viral Load Difference between Symptomatic and Asymptomatic COVID-19 Patients: Systematic Review and Meta-Analysis.

TL;DR: In this article, the authors conducted a systematic review and meta-analysis to investigate the possible difference in the SARS-CoV-2 viral load between asymptomatic and symptomatic COVID-19 patients.
Journal ArticleDOI

Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review.

TL;DR: This review summarized and critically analyzed the most significant findings linking HDL accessory proteins and AD and discusses the most convincing hypothesis explaining the mechanism by which an observed systemic occurrence may have repercussions in the brain.
Journal ArticleDOI

A new corrective model to evaluate TBS in obese post-menopausal women: a cross-sectional study.

TL;DR: TBS, once removed the effect of BMI, can serve as a good surrogate maker of bone microarchitecture in obese post-menopausal women in addition to BMD.
Journal ArticleDOI

Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools.

TL;DR: All fracture risk assessment tools appeared to be effective in predicting bone fractures in T2DM postmenopausal women, with DeFRA showing a slightly better diagnostic accuracy.
Journal ArticleDOI

Assessment of Fracture Risk in A Population of Postmenopausal Italian Women: A Comparison of Two Different Tools.

TL;DR: Findings would suggest that DeFRA might be ascribed as at least equivalent to FRAX or perhaps slightly most appropriate in the categorization of the fracture risk, particularly in women aged 60–69 years, a period in which bone densitometry analysis is highly recommended.